Clinical Trials Insight: 700052515
Phase of Trial: Phase I
Latest Information Update: 27 Oct 2010
At a glance
- Drugs IPI 940 (Primary)
- Indications Inflammatory pain; Neuropathic pain
- Focus Adverse reactions
- 27 Oct 2010 Results were reported in an Infinity media release.
- 27 Oct 2010 Status changed from planning to completed according to results reported in an Infinity media release.
- 13 Jan 2010 New trial record